Gary Ingenito is Chief Med. & Reg. Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 55,849 shares of CPRX, which is worth approximately $1.22 Million. The most recent transaction as insider was on Jun 21, 2022, when has been sold 143,848 shares (Common Stock, par value $0.001 per share) at a price of $4.13 per share, resulting in proceeds of $594,092. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.8K
8.67% 3M change
27.43% 12M change
Total Value Held $1.22 Million

GARY INGENITO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2022
BUY
Exercise of conversion of derivative security
$594,092 $4.13 p/Share
143,848 Added 46.44%
165,901 Common Stock, par valu...
Dec 07 2021
SELL
Open market or private sale
$25,248 $6.99 p/Share
3,612 Reduced 14.07%
22,053 Common Stock, par valu...
Dec 07 2021
BUY
Exercise of conversion of derivative security
-
14,667 Added 36.37%
25,665 Common Stock, par valu...
Dec 22 2020
SELL
Open market or private sale
$12,655 $3.45 p/Share
3,668 Reduced 25.01%
10,998 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
14,666 Added 50.0%
14,666 Common Stock, par valu...
GI

Gary Ingenito

Chief Med. & Reg. Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX